经导管二尖瓣治疗
Transcatheter mitral valve therapies.
作者信息
Yadava Om Prakash, Bapat Vinayak
机构信息
National Heart Institute, New Delhi, India.
Kings College, London, UK.
出版信息
Indian J Thorac Cardiovasc Surg. 2019 Jul;35(3):520-521. doi: 10.1007/s12055-019-00805-2. Epub 2019 Mar 1.
Dr.O.P. Yadava, Editor-in-Chief, IJTC and Dr. V Bapat, Assistant Professor at Columbia University, New York, discuss issues related to slow development and uptake of transcatheter mitral valve replacement. Dr. Bapat stresses on the basic difference between transcatheter aortic and mitral valve interventions. He laments that issues related to mitral valve repair versus replacement and role of percutaneous MitraClip are still being hotly debated. He, however, is hopeful that technology shall evolve to make percutaneous options for secondary mitral regurgitation a viable proposition.
《国际心胸外科杂志》主编O.P. 亚达瓦博士与纽约哥伦比亚大学助理教授V·巴帕特博士讨论了经导管二尖瓣置换术发展缓慢及应用率低的相关问题。巴帕特博士强调了经导管主动脉瓣和二尖瓣介入治疗的根本区别。他感到遗憾的是，二尖瓣修复与置换相关问题以及经皮MitraClip装置的作用仍在激烈争论中。不过，他希望技术能够不断发展，使经皮治疗继发性二尖瓣反流成为可行的方案。
Zotero 插件